117-hr-8440117th Congress

Right to Try Clarification Act

Sponsored By: Representative Blumenauer, Earl [D-OR-3]

Unknown

Summary

Right to Try Clarification Act This bill specifies that investigational drugs that are provided directly to individuals from manufacturers without the need for federal regulatory approval (i.e., via the Right to Try pathway) are exempt from restrictions that would otherwise apply under the Controlled Substances Act (e.g., restrictions on the use or possession of schedule I controlled substances).

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Blumenauer, Earl [D-OR-3]

OR • D

Cosponsors

  • Rep. Mace, Nancy [R-SC-1]

    SC • R

    Sponsored 7/20/2022

  • Rep. Dean, Madeleine [D-PA-4]

    PA • D

    Sponsored 7/20/2022

  • Rep. Biggs, Andy [R-AZ-5]

    AZ • R

    Sponsored 7/20/2022

  • Rep. Correa, J. Luis [D-CA-46]

    CA • D

    Sponsored 7/20/2022

  • Del. Norton, Eleanor Holmes [D-DC-At Large]

    DC • D

    Sponsored 8/16/2022

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation